Founded by research scientists and entrepreneurs in 2002, GenomeScan is a privately-owned company based in Leiden, The Netherlands. GenomeScan is a leading and innovative company in the field of genetic analyses. The company’s mission is to partner with hospitals, academic institutions, and global pharmaceutical and biotechnology companies to accelerate disease diagnostics and prediction, support clinician decision making, and improve the quality of life for patients suffering from genetic disorders. GenomeScan truly understands customers’ needs and develops tailored solutions. The company combines in-house expertise with a close collaboration with clinical experts from the prestigious Erasmus Medical Center and Leiden University Medical Center to develop an in-depth knowledge and understanding of a wide range of research methodologies and data-analysis and -interpretation relevant to clinical practice. In addition to providing patient stratification strategies based on NGS genetic profiling to pharmaceutical companies, GenomeScan’s services portfolio encompasses the latest sequencing technologies including whole exome sequencing, panel sequencing, transcriptomics, and epigenetics.
Something looks off?